NewLink's indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3% [Seeking Alpha]
NEWLINK GENETICS (NLNK)
Last newlink genetics earnings: 2/28 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.linkp.com/investor-relations
Company Research
Source: Seeking Alpha
NewLink Genetics ( NLNK ) is up on below-average volume on its announcement of updated data from a Phase 1 clinical trial assessing indoximod + front-line radiation + maintenance chemo in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG), a treatment-resistant and aggressive type of tumor that starts in the brain stem. The results were presented at the International Symposium of Pediatric Neuro-Oncology Annual Meeting in Denver, CO. All 10 treated patients showed initial symptomatic improvement. Nine of the 10 remain on study, the longest being 8.5 months. Historically, median survival is only nine months. On the safety front, an unspecified subset of patients experienced adverse events, including inflammation, which were actively managed. See all stocks on the move » Now read: NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback »
Show less
Read more
Impact Snapshot
Event Time:
NLNK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NLNK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NLNK alerts
High impacting NEWLINK GENETICS news events
Weekly update
A roundup of the hottest topics